Patent Case Watch

Patent opinions from the Eastern District of Texas and the U.S. Court of Appeals for the Federal Circuit

E.D. Tex.

Allergan, Inc. v. Sandoz Inc, No. 6:11-cv-00441 (E.D. Tex. Jan. 10, 2013)

Claims Construed
Claim Construction
Court
U.S. District Court for the Eastern District of Texas, Tyler Division
Case No.
No. 6:11-cv-00441, Dkt. No. 118
Decided
January 10, 2013
Judge
Michael H. Schneider, J.
Document
Memorandum Opinion and Order
Docket Entry
MEMORANDUM OPINION AND ORDER construing the disputed claim terms of U.S. Patent No. 7,851,504 entitled Enhanced Bimatoprost Opthalmic Solution
Length
16 pages

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

This claim construction order construes the disputed claim terms of U.S. Patent No. 7,851,504 (‘504 patent) entitled “Enhanced Bimatopr ost Opthalmic Solution.” 1 On September 27, 2012, the Court held a claim construction hearing to construe the disputed terms. For the following reasons, the Court adopts the constructions set forth below. I. BACKGROUND This is a patent infringement action fil ed pursuant to the Hatch -Waxman Act. Congress passed the Hatch -Waxman Act in 1984 to promote the manufacturing of generic pharmaceuticals.

Download Opinion (PDF)

Source: govinfo.gov USCOURTS collection · retrieved July 23, 2026 · Report an error

Other documents in this case